Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

A review of human heart models—cardiac organoids and organ chips—showed that each method has unique advantages in different research contexts, including cardiac disease modeling and drug development.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

At the University of Oklahoma, Prof. Indrajeet Sharma is leading a team of scientists that is working on a ‘skeletal editing’ ...